A curated stream of high-signal insights across Technology, Healthcare, Lifesciences, AI, Oncology, Business, Entrepreneurship, Leadership, Philosophy and beyond.
Thoughtful, cross-disciplinary content designed to expand how you think, not just what you know.
No noise. Only substance.
Everyone watches HAL and the big shipyards land the headline contracts.
But the quiet winners are the Tier-2 subsystem suppliers — the ones building radars, avionics, and electronics.
India is the “Pharmacy of the World”— not by accident, but by design.
The 1970 Patents Act flipped the script: instead of product patents (owning the molecule), India allowed process patents. Any company could legally manufacture the same drug using a different method — making patented medicines up to 99% cheaper.
BCG (2026)
Most companies don’t die from external shocks — they rot from the inside.
India never lacked desire — it lacked liquidity and timing.
Instead of waiting for incomes to rise, Indian companies mastered three ways to hide the gap between what people want and what they can afford:
Every year founders chase the “IRL connection economy” — market of businesses that create and monetize real-world, offline connections and experiences (think premium clubs, event platforms, fitness communities) - a supposed $400B market.
Most fail.
Urgency often looks like leadership — frantic reactions, constant escalations, visible busyness.
But it usually creates noise, disrupts teams, and ignores root causes.
